Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2000, p. 625-629, Vol. 38, No. 2
Department of Microbiology, Kitasato
University School of Medicine, Sagamihara, Kanagawa
228-8555,1 Department of
Otolaryngology, Tohoku Rosai Hospital, Aoba-ku, Sendai
981-09113 and Department of
Otolaryngology, Nagasaki University School of Medicine, Nagasaki
852-8501,2 Japan
Received 9 August 1999/Returned for modification 27 September
1999/Accepted 30 November 1999
To investigate how bacterial pathogens spread from child to child
in a day care center, we monitored six children, two boys and four
girls, born between August 1995 and November 1997, attending a day care
center and analyzed nasopharyngeal samples from them using pulsed-field
gel electrophoresis (PFGE). We obtained nasopharyngeal cultures from
all of the affected children and almost all of the unaffected children
between September 1998 and March 1999 after some children presented
simultaneously with purulent rhinorrhea. Moreover, when a child was
found to have acute otitis media, nasopharyngeal secretions from the
child were independently cultured during treatment. During this period,
28 isolates of Moraxella catarrhalis, 13 of Streptococcus pneumoniae, and 4 of Haemophilus
influenzae were recovered. PFGE gave 8 patterns for M. catarrhalis, 10 for S. pneumoniae, and 1 for H. influenzae. PFGE patterns demonstrated spread of M. catarrhalis between children. However, each occurrence of
clusters of infection with M. catarrhalis lasted 2 to 6 weeks, with a change in PFGE pattern between occurrences of clusters. The M. catarrhalis strain infecting each child also
changed. Similarly, the S. pneumoniae strain in each child
also changed. In contrast, infection with H. influenzae
persisted for about 3 months in an affected child.
Acute otitis media (AOM) is the most
common disease of the upper respiratory airway in childhood and occurs
at least once in about two-thirds of children under 3 years of age
(17). Recurrent AOM (rAOM) tends to occur in children under
2 years of age, particularly with episodes of AOM in the first year of
life (9).
AOM has a multifactorial etiology, and risk factors for rAOM are
classified by host, bacterial, and environmental characteristics. Host
factors include immature immunity (15), lack of breast feeding, and tubal dysfunction (4). With respect to
bacterial factors, penicillin-resistant Streptococcus
pneumoniae has become a major concern in respiratory tract
infections in children. Recent studies have shown a high incidence of
penicillin-resistant S. pneumoniae in middle ear secretions
(6). As for environmental factors, the relationship between
day care center attendance and occurrence of otitis media was reported
by Hesselvic (8) as early as 50 years ago. Since then, many
other studies have shown that day care center attendance is a strong
risk factor for rAOM compared with care at home (7, 14, 16).
Although attendance at a day care center is a risk factor for rAOM, no
epidemiologic study has demonstrated that children acquire infecting
organisms from other children. Moreover, the incidence of rAOM has
increased recently, with some children requiring hospitalization and
treatment with injectable antibiotics because of persistent purulent
otorrhea, high fever, and complications, e.g., bacterial meningitis.
Therefore, it is important to analyze clinical nasopharyngeal samples
from children attending day care centers. In this study, we analyzed
nasopharyngeal cultures from children attending a day care center and
investigated how bacterial pathogens spread from child to child in this
setting, using pulsed-field gel electrophoresis (PFGE).
Monitoring.
We prospectively monitored six children
attending a day care center attached to Tohoku Rosai Hospital in Sendai
City from December 1997 to March 1999. The six children, two boys and
four girls, were born between August 1995 and November 1997. Five
children were between the ages of 7 months and 2 years 4 months when
our study started. The other one was 6 months old when the child
entered the day care center in May 1998. These six children were the
only ones in the day care center and were cared for in one room
measuring about 6 by 8 m.
Nasopharyngeal cultures.
Between September 1998 and March
1999, when some children presented simultaneously with purulent
rhinorrhea, nasopharyngeal secretions from all of the affected children
and almost all of the unaffected children were cultured by an
otolaryngologist (M.S.). In addition, when a child was found to have
AOM, nasopharyngeal secretions from the child were independently
cultured during treatment. The diagnosis of AOM was made by the same
otolaryngologist. This study protocol was approved by Tohoku Rosai
Hospital's ethics committee.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Pulsed-Field Gel Electrophoresis Analysis of
Nasopharyngeal Flora in Children Attending a Day Care Center
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Antimicrobial agents. Reference powders of different drugs with known potency were as follows: benzylpenicillin (Banyu Pharmaceutical Co., Ltd., Tokyo, Japan), ampicillin (Meiji Seika Kaisha., Ltd., Tokyo, Japan), clavulanic acid (SmithKline Beecham Pharmaceuticals, Surrey, United Kingdom), cefaclor (Eizai Co., Ltd., Tokyo, Japan), cefpodoxime (Sankyo Co., Ltd., Tokyo, Japan), cefditoren (Meiji Seika Kaisha), cefotiam (Takeda Chemical Industries, Ltd., Osaka, Japan), cefmetazole (Sankyo Co.), cefotaxime (Nippon Hoechst Marion Roussel, Tokyo, Japan), and imipenem (Banyu Pharmaceutical Co.). All of these were the kind gifts of the respective manufactures.
MIC determinations. MICs were determined in Sensitivity Test Agar (Mueller-Hinton agar medium; Eiken Chemical Co.) with Strepto Haemo supplement (Eiken Chemical Co.) by agar dilution with an inoculum of 5 × 104 CFU/spot delivered by a Microplanter inoculator (Sakuma Seisaku, Tokyo, Japan). The MIC of each drug was scored after 18 h of incubation at 35°C (10).
Genotyping. M. catarrhalis, S. pneumoniae, and H. influenzae were grown in Mueller-Hinton broth (Eiken Chemical Co.) with Strepto Haemo supplement (Eiken Chemical Co.) at 35°C for 16 h. The cells were harvested by centrifugation at 4,000 × g and 4°C for 5 min, washed with a saline-EDTA solution (0.15 M NaCl, 10 mM EDTA [pH 8.0]), and resuspended in a Pett IV solution (1 M NaCl, 10 mM EDTA [pH 8.0]). An equal volume of melted 2.0% low-melting-point agarose (InCert agarose; FMC BioProducts, Rockland, Maine) was added to this suspension. The mixture was poured into an insert former and chilled at 4°C for 20 min. The plugs removed from the former were treated at 37°C with 1 to 5 mg of lysozyme (Seikagaku Co., Tokyo, Japan) per ml of lysis solution (1 M NaCl, 0.1 M EDTA [pH 8.0], 10 mM Tris-HCl, 0.5% Brij 58, 0.2% sodium deoxycholate, 0.5% Sarkosyl). After 12 h, the lysis solution was decanted and replaced with 0.1 to 1.0 mg of proteinase K (Wako Pure Chemical Industries, Ltd., Osaka, Japan) per ml of ES solution (0.25 M EDTA [pH 8.0], 1% Sarkosyl) at 50°C for 24 h. The ES solution was decanted, and the plugs were placed in TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA [pH 8.0]) containing 1 mM phenylmethylsulfonyl fluoride at room temperature for 4 h. Next, the plugs were washed in TE buffer for 20 min at room temperature. For restriction endonuclease digestion, the plugs were incubated in enzyme restriction buffer for 30 min at room temperature to remove the EDTA. The plugs were incubated in restriction enzyme buffer with 20 U of SpeI (TaKaRa Shuzo Co., Ltd., Kyoto, Japan), NotI (TaKaRa Shuzo Co.), and NheI (TaKaRa Shuzo Co.) for M. catarrhalis isolates; SmaI (TaKaRa Shuzo Co.) and ApaI (TaKaRa Shuzo Co.) for S. pneumoniae isolates; and SmaI (TaKaRa Shuzo Co.) and SpeI (TaKaRa Shuzo Co.) for H. influenzae isolates, respectively. The digestions with SpeI, NotI, NheI, and ApaI were performed at 37°C, and those with SmaI were done at 30°C for 16 h, respectively.
Electrophoresis was performed using a CHEF Mapper (Bio-Rad Laboratories, Hercules, Calif.). Agarose gels were prepared at a 1% concentration in 0.5× TBE buffer (45 mM Tris base, 45 mM boric acid, 1 mM EDTA [pH 8.0]). Separation of fragments was done at 6 V/cm at 14°C for 20 h 18 min. The pulse time, which changed linearly, was 0.47 to 63.80 s. Lambda Ladder (Bio-Rad Laboratories) was used as the size standard. The gel was stained for 30 min in ethidium bromide at 1 µg/ml and decolorized in distilled water for 15 min. The gel was photographed by UV transillumination.| |
RESULTS |
|---|
|
|
|---|
Occurrence of upper respiratory infection and AOM.
All of the
children had upper respiratory infections during the monitoring period.
Five children (83%) had at least one episode of AOM, and four had more
than four episodes (Table 1). Although child 3 did not have AOM before entrance into the day care center, he
had rAOM episodes after entrance. On the other hand, children 2 and 5 rarely had episodes of AOM during the monitoring period, although they
attended the same day care center.
|
Nasopharyngeal culture. Between September 1998 and March 1999, 28 isolates of M. catarrhalis, 13 of S. pneumoniae, and 4 of H. influenzae were recovered from the six children, mainly from the nasopharynx.
PFGE. We examined whether isolates from the nasopharynx belonged to the same strain by PFGE after cutting chromosomal DNA with two or three restriction enzymes. As shown in Fig. 1, we obtained 8 PFGE patterns from M. catarrhalis isolates, 10 from S. pneumoniae isolates, and 1 from H. influenzae isolates. The isolates which showed the same PFGE pattern with one restriction enzyme were identified as the same strains after digestion with the other enzymes for each organism. We designated these strains M1 to M8, S1 to S10, and H, respectively.
|
Spread of bacteria in the day care center.
Clusters of
infections with M. catarrhalis strains M1, M2, M4, and M7
occurred in children attending the day care center from September 1998 to March 1999. However, the duration of each occurrence of clusters of
infection lasted 2 to 6 weeks. The PFGE pattern of the M. catarrhalis strains changed between periods of clusters. Similarly, the strain of M. catarrhalis changed in each
child in the day care center between periods of infection (Table
2).
|
MIC determinations.
The MICs of 10 antibiotics against 28 isolates of M. catarrhalis, 13 of S. pneumoniae,
and 4 of H. influenzae were determined. When we compared
susceptibility patterns with PFGE profiles, the MICs were almost equal
for the strains which showed the same PFGE profile. Therefore, the MICs
for the representative strains which showed different PFGE profiles are
shown in Table 3.
|
-lactamase activity, all strains of
M. catarrhalis and H. influenzae were considered
to produce penicillinase. In addition, All M. catarrhalis
and H. influenzae isolates were considered to produce
penicillinase by the P/Case test (Showa Chemical Co., Ltd., Tokyo,
Japan). Of the 10 strains of S. pneumoniae, 3 were resistant
to benzylpenicillin (MIC,
2.0 µg/ml) and 4 showed intermediate
resistance (0.1 µg/ml
MIC
1.0 µg/ml).
| |
DISCUSSION |
|---|
|
|
|---|
AOM is a major health problem of childhood. In the past, it was easy for physicians to treat AOM with antibiotics. However, the incidence of rAOM has increased recently, with some children requiring hospitalization and treatment with injectable antibiotics because of persistent purulent otorrhea and high fever. Such severe AOM has the possibility of suppurative complications, e.g., bacterial meningitis or brain abscess. Generally, the parents of children who attend day care centers have jobs outside the home. Thus, rAOM represents a significant burden when outpatient treatment fails. Moreover, rAOM is recognized as a social problem because of the associated high medical expenses.
Although rAOM has been reported to be associated with attendance at day care centers (7, 14, 16), no epidemiologic study has demonstrated that children acquire infecting organisms from either other children or the same children at different times. Neither has molecular biology been used to characterize the infecting agent, thereby establishing the mode of infection. Therefore, it is important to analyze isolates from the nasopharynges of children attending day care centers to answer these questions. In this study, we investigated bacteria in serial nasopharyngeal cultures repeatedly in children attending a day care center, using PFGE.
The usefulness of epidemiological typing of the strains of a bacterial species by PFGE for genomic DNA has been well established (2). At first, we analyzed PFGE patterns using SpeI for M. catarrhalis and SmaI for S. pneumoniae and H. influenzae. As a result, we obtained 8 PFGE patterns from M. catarrhalis isolates, 10 from S. pneumoniae isolates, and 1 from H. influenzae isolates. To indicate that the strains showing indistinguishable PFGE patterns are indeed the same, we further analyzed PFGE patterns using NotI and NheI for M. catarrhalis, ApaI for S. pneumoniae, and SpeI for H. influenzae. As for S. pneumoniae and H. influenzae, the isolates which showed the same PFGE pattern with the first restriction enzyme were identified as the same strains after digestion with another enzyme. As for some M. catarrhalis strains, it was very difficult to obtain PFGE bands with NotI (M4, M5, and M8) and NheI (M3 and M7) for unknown reasons. However, by using both NotI and NheI, we found that the strains showing indistinguishable PFGE patterns with SpeI were indeed the same.
In analyzing the restriction patterns, we referred to Tenover's guidelines to determine the relatedness of bacterial isolates (18). As a result of PFGE, restriction patterns were divided into two types: one is indistinguishable patterns, and the other is differences of more than four bands in each organism. Strains showing differences of more than four bands were considered unrelated because the isolates were collected within a short period (6 months) and taken from small populations (18).
Table 1 shows the clinical courses of all of the children studied with regard to AOM and upper respiratory infections between December 1997 and March 1999. There were many AOM episodes. Child 3 had no attacks prior to entrance into the day care center but had several consecutive episodes of AOM after entrance. Attendance at a day care center seemed to be a causative factor for rAOM in this case. However, children 2 and 5 rarely experienced episodes of AOM despite their attendance at the same day care center. This suggests that host factors are also very important and that AOM is a multifactorial disease.
There were five epidemic episodes of upper respiratory infection, including AOM, among the children attending the day care center between September 1998 and March 1999. M. catarrhalis was cultured repeatedly during these episodes. Twenty-eight M. catarrhalis isolates obtained from the nasopharynges of the six children were classified into eight strains by means of PFGE. Table 2 shows the spread of a particular M. catarrhalis isolate from one child to another.
For example, strain M4 was isolated from child 1 on 24 November 1998. This strain spread to children 3, 5, and 6. However, the presence of clusters of infection with M4 had ended by 15 December 1998. Strain M7 was then isolated from child 6 on 21 January 1999. After 4 days, this strain spread to children 1, 3, and 4. Finally, the strain spread to all of the children in the day care center except child 2. When the next clusters of infection with M. catarrhalis occurred, the strains had changed, as shown by their PFGE patterns. The strain of M. catarrhalis infecting each child also changed. For example, four different strains of M. catarrhalis were isolated one after another from child 3 during this period. The mechanism of the observed turnover may be very complex and probably involves many factors.
M. catarrhalis is frequently part of the nasopharyngeal
microflora of small children, especially during episodes of AOM.
M. catarrhalis can be transmitted in the hospital
(1), as well as in the community (12). M. catarrhalis has become increasingly recognized as a cause of upper
and lower respiratory tract infections. An important characteristic of
M. catarrhalis is that most isolates produce
-lactamase
(5); the enzyme produced by M. catarrhalis hydrolyzes not only penicillins but also cephalosporins. The phenomenon of indirect pathogenicity in mixed infections, in which a pathogen such
as S. pneumoniae and H. influenzae is protected
by an enzyme produced by another organism, is well recognized
(3). In this study, the isolates obtained from S. pneumoniae and H. influenzae were in mixed infections
with M. catarrhalis and all of the M. catarrhalis
isolates produced
-lactamases; thus, it was important to inhibit
these enzymes to treat S. pneumoniae and H. influenzae infections.
One episode of spread of S. pneumoniae from child 3 to child 6 was recognized (Table 2). However, the clusters of infection with S. pneumoniae and H. influenzae could not been measured in this study. As with M. catarrhalis strains, the S. pneumoniae strain changed in each child with the next upper respiratory infection, including episodes of AOM. For example, three different strains of S. pneumoniae were isolated, one after another, from child 3 during this period.
Four H. influenzae isolates were recovered from the nasopharynges of six children. PFGE showed that these isolates belonged to the same strain. Infection with H. influenzae, unlike infection with M. catarrhalis and S. pneumoniae, persisted for about 3 months in child 3. Therefore, we assume that elimination of H. influenzae from the nasopharynx is difficult, compared with that of M. catarrhalis and S. pneumoniae. Studies addressing this question are under way in our laboratory.
| |
ACKNOWLEDGMENT |
|---|
This work was supported in part by grant-in-aid 09670296 from the Ministry of Science, Education and Culture of Japan, awarded to M. Inoue.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Kitasato University School of Medicine, Sagamihara, Kanagawa 228-8555, Japan. Phone: 81-42-778-9349. Fax: 81-42-778-9350. E-mail: matsu{at}kitasato-u.ac.jp.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ahmad, F., D. T. McLeod, J. T. Power, and M. A. Calder. 1985. Branhamella catarrhalis prevalence in a hospital population. J. Hosp. Infect. 6:71-74[CrossRef][Medline]. |
| 2. | Arbeit, R. D. 1995. Laboratory procedures for the epidemiologic analysis of microorganisms, p. 190-208. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. |
| 3. |
Brook, I.
1989.
The concept of indirect pathogenicity by beta-lactamase production, especially in ear, nose and throat infection.
J. Antimicrob. Chemother.
24(Suppl. B):63-72 |
| 4. | Bylander, A. 1986. Pathophysiological aspects on eustachian tube function and SOM. Scand. Audiol. Suppl. 26:59-63[Medline]. |
| 5. |
Doern, G. V.,
R. N. Jones,
M. A. Pfaller,
K. Kugler, and The Sentry Participants Group.
1999.
Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997).
Antimicrob. Agents Chemother.
43:385-389 |
| 6. | Gehanno, P., L. N'Guyen, M. Derriennic, F. Pichon, J. M. Goehrs, and P. Berche. 1998. Pathogens isolated during treatment failures in otitis. Pediatr. Infect. Dis. J. 7:885-890. |
| 7. |
Hardy, A. M., and M. G. Fowler.
1993.
Child care arrangements and repeated ear infections in young children.
Am. J. Public Health
83:1321-1325 |
| 8. | Hesselvik, L. 1949. Respiratory infections among children in day nurseries. Acta. Paediatr. Scand. Suppl. 74:1-103. |
| 9. | Howie, V. M., J. H. Ploussard, and J. Sloyer. 1975. The "otitis-prone" condition. Am. J. Dis. Child. 129:676-678[Abstract]. |
| 10. | Inoue, M., R. Okamoto, T. Okubo, K. Inoue, and S. Mitsuhashi. 1992. Comparative in vitro activity of RP59500 against clinical bacterial isolates. J. Antimicrob. Chemother. 30(Suppl. A):45-51. |
| 11. |
Katsu, K.,
M. Inoue, and S. Mitsuhashi.
1982.
Transposition of the carbenicillin-hydrolyzing beta-lactamase gene.
J. Bacteriol.
150:483-489 |
| 12. | McLeod, D. T., F. Ahmad, J. T. Power, M. A. Calder, and A. Seaton. 1983. Bronchopulmonary infection due to Branhamella catarrhalis. Br. Med. J. (Clin. Res. Ed.) 12:1446-1447. |
| 13. | Morello, J. A., W. M. Janda, and M. Bohnhoff. 1995. Neisseria and Branhamella, p. 324-340. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. |
| 14. |
Niemela, M.,
M. Uhari, and M. Mottonen.
1995.
A pacifier increases the risk of recurrent acute otitis media in children in day care centers.
Pediatrics
96:884-888 |
| 15. | Prellner, K., O. Kalm, and F. K. Pedersen. 1984. Pneumococcal antibodies and complement during and after periods of recurrent otitis. Int. J. Pediatr. Otorhinolaryngol. 7:39-49[CrossRef][Medline]. |
| 16. | Pukander, J., J. Luotonen, M. Timonen, and P. Karma. 1985. Risk factors affecting the occurrence of acute otitis media among 2-3-year-old urban children. Acta Oto-laryngol. 100:260-265[Medline]. |
| 17. | Teele, D. W., J. O. Klein, and B. Rosner. 1989. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160:83-94[Medline]. |
| 18. | Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|